Nikita Trojanskis is Co-Founder and CEO of Amorphous AI, building the world's first marketplace for real-time structured healthcare data through an AI platform that turns unstructured clinical notes into actionable insights.

Nikita holds a PhD in Computational Biology and Machine Learning at the University of Oxford, where his research focuses on using AI to predict future SARS-CoV-2 strains and advance proactive epidemic surveillance.

Nikita led the only epidemiological modelling effort during Latvia's COVID-19 pandemic, responding directly to the Minister of Health, and also led the development of the first decentralised contact-tracing app in the EU.

Prior to Amorphous AI, Nikita worked at UNAIDS in Geneva, served at the Ministry of Health of the Republic of Latvia and the State Chancellery, and contributed as an editor at the global health think tank Polygeia.

Amorphous AI's Striata AI analyst achieves 97.8% recall on clinical entity extraction and completes complex end-to-end analytics benchmarks in minutes, backed by leading VCs including Specialist VC, Calm/Storm, and Plug and Play.